Spitting image: can saliva biomarkers reflect Alzheimer's disease?

by Nicholas J. Ashton, Kaj Blennow, Henrik Zetterberg
Published 2021-06-01

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

by Nicholas J. Ashton, Mark Ide, Henrik Zetterberg, Kaj Blennow
Published 2019-12-01

Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population

by Helena Sophia Gleerup, Federica Sanna, Peter Høgh, Peter Høgh, Joel Simrén, Joel Simrén, Kaj Blennow, Kaj Blennow, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Steen Gregers Hasselbalch, Steen Gregers Hasselbalch, Nicholas J. Ashton, Nicholas J. Ashton, Nicholas J. Ashton, Nicholas J. Ashton, Anja Hviid Simonsen
Published 2021-05-01

Fluid Biomarkers for Synaptic Dysfunction and Loss

by Elena Camporesi, Johanna Nilsson, Ann Brinkmalm, Bruno Becker, Nicholas J Ashton, Kaj Blennow, Henrik Zetterberg
Published 2020-08-01

Comparing Glial Fibrillary Acidic Protein (GFAP) in Serum and Plasma Following Mild Traumatic Brain Injury in Older Adults

by Nathan A. Huebschmann, Nathan A. Huebschmann, Teemu M. Luoto, Justin E. Karr, Justin E. Karr, Justin E. Karr, Justin E. Karr, Justin E. Karr, Ksenia Berghem, Kaj Blennow, Kaj Blennow, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Nicholas J. Ashton, Nicholas J. Ashton, Nicholas J. Ashton, Nicholas J. Ashton, Joel Simrén, Joel Simrén, Jussi P. Posti, Jessica M. Gill, Grant L. Iverson, Grant L. Iverson, Grant L. Iverson, Grant L. Iverson, Grant L. Iverson
Published 2020-09-01

Proteomic blood profiling in mild, severe and critical COVID-19 patients

by Hamel Patel, Nicholas J. Ashton, Richard J. B. Dobson, Lars-Magnus Andersson, Aylin Yilmaz, Kaj Blennow, Magnus Gisslen, Henrik Zetterberg
Published 2021-03-01

Full-length and C-terminal neurogranin in Alzheimer’s disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays

by Annika Öhrfelt, Julien Dumurgier, Henrik Zetterberg, Agathe Vrillon, Nicholas J. Ashton, Hlin Kvartsberg, Elodie Bouaziz-Amar, Jacques Hugon, Claire Paquet, Kaj Blennow
Published 2020-12-01

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result

by Sarah Westwood, Alison L. Baird, Abdul Hye, Abdul Hye, Nicholas J. Ashton, Nicholas J. Ashton, Nicholas J. Ashton, Alejo J. Nevado-Holgado, Sneha N. Anand, Benjamine Liu, Danielle Newby, Chantal Bazenet, Steven J. Kiddle, Steven J. Kiddle, Malcolm Ward, Ben Newton, Keyur Desai, Cristina Tan Hehir, Michelle Zanette, Daniela Galimberti, Daniela Galimberti, Lucilla Parnetti, Alberto Lleó, Susan Baker, Vaibhav A. Narayan, Wiesje M. van der Flier, Wiesje M. van der Flier, Philip Scheltens, Charlotte E. Teunissen, Pieter Jelle Visser, Simon Lovestone
Published 2018-12-01

Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up

by Nelly Kanberg, Joel Simrén, Arvid Edén, Lars-Magnus Andersson, Staffan Nilsson, Nicholas J. Ashton, Pär-Daniel Sundvall, Bengt Nellgård, Kaj Blennow, Henrik Zetterberg, Magnus Gisslén
Published 2021-08-01

Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration

by Nicholas J. Ashton, Antoine Leuzy, Yau Mun Lim, Claire Troakes, Tibor Hortobágyi, Kina Höglund, Dag Aarsland, Simon Lovestone, Michael Schöll, Kaj Blennow, Henrik Zetterberg, Abdul Hye
Published 2019-01-01

Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers

by Nicholas J. Ashton, Marc Suárez-Calvet, Amanda Heslegrave, Abdul Hye, Cristina Razquin, Pau Pastor, Raquel Sanchez-Valle, José L. Molinuevo, Pieter Jelle Visser, Kaj Blennow, Angela K. Hodges, Henrik Zetterberg
Published 2019-11-01

Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer’s disease pathology

by Azhaar Ashraf, Nicholas J. Ashton, Pratishtha Chatterjee, Kathryn Goozee, Kaikai Shen, Jurgen Fripp, David Ames, Christopher Rowe, Colin L. Masters, Victor Villemagne, Abdul Hye, Ralph N. Martins, Po-Wah So, AIBL
Published 2020-06-01

Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative

by Anna Zettergren, Jodie Lord, Nicholas J. Ashton, Andrea L. Benedet, Thomas K. Karikari, Juan Lantero Rodriguez, the Alzheimer’s Disease Neuroimaging Initiative*, Anniina Snellman, Marc Suárez-Calvet, Petroula Proitsi, Henrik Zetterberg, Kaj Blennow
Published 2021-01-01

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease

by Carla M. Startin, Nicholas J. Ashton, Sarah Hamburg, Rosalyn Hithersay, Frances K. Wiseman, Kin Y. Mok, John Hardy, Alberto Lleó, Simon Lovestone, Lucilla Parnetti, Henrik Zetterberg, Abdul Hye, LonDownS Consortium, André Strydom
Published 2019-03-01

Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and Univ...

by Pawel Obrocki, Ayesha Khatun, Deborah Ness, Konstantin Senkevich, Jörg Hanrieder, Federica Capraro, Niklas Mattsson, Ulf Andreasson, Erik Portelius, Nicholas J. Ashton, Kaj Blennow, Michael Schöll, Ross W. Paterson, Jonathan M. Schott, Henrik Zetterberg
Published 2020-02-01

The reliability and validity of DSM 5 diagnostic criteria for neurocognitive disorder and relationship with plasma neurofilament light in a down syndrome population

by Sarah E. Pape, Tamara al Janabi, Nicholas J. Ashton, Abdul Hye, Rory Sheehan, Paul Gallagher, Bernice Knight, Anne-Marije Prins, Ken Courtenay, Vesna Jordanova, Bini Thomas, Nagarajan Perumal, Craig Forbes, Angela Hassiotis, Andre Strydom
Published 2021-06-01

Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid‐positive individuals

by Andréa L. Benedet, Nicholas J. Ashton, Tharick A. Pascoal, Antoine Leuzy, Sulantha Mathotaarachchi, Min S. Kang, Joseph Therriault, Melissa Savard, Mira Chamoun, Michael Schöll, Eduardo R. Zimmer, Serge Gauthier, Aurélie Labbe, Henrik Zetterberg, Kaj Blennow, Pedro R. Neto, Alzheimer's Disease Neuroimaging Initiative
Published 2019-12-01

Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease

by Pratishtha Chatterjee, Henrik Zetterberg, Kathryn Goozee, Chai K. Lim, Kelly R. Jacobs, Nicholas J. Ashton, Abdul Hye, Steve Pedrini, Hamid R. Sohrabi, Tejal Shah, Prita R. Asih, Preeti Dave, Kaikai Shen, Kevin Taddei, David B. Lovejoy, Gilles J. Guillemin, Kaj Blennow, Ralph N. Martins
Published 2019-10-01

Relevance of biomarkers across different neurodegenerative

by Alexander J. Ehrenberg, Ayesha Khatun, Emma Coomans, Matthew J. Betts, Federica Capraro, Elisabeth H. Thijssen, Konstantin Senkevich, Tehmina Bharucha, Mehrsa Jafarpour, Peter N. E. Young, William Jagust, Stephen F. Carter, Tammaryn Lashley, Lea T. Grinberg, Joana B. Pereira, Niklas Mattsson-Carlgren, Nicholas J. Ashton, Jörg Hanrieder, Henrik Zetterberg, Michael Schöll, Ross W. Paterson
Published 2020-05-01

Correction to: Relevance of biomarkers across different neurodegenerative diseases

by Alexander J. Ehrenberg, Ayesha Khatun, Emma Coomans, Matthew J. Betts, Federica Capraro, Elisabeth H. Thijssen, Konstantin Senkevich, Tehmina Bharucha, Mehrsa Jafarpour, Peter N. E. Young, William Jagust, Stephen F. Carter, Tammaryn Lashley, Lea T. Grinberg, Joana B. Pereira, Niklas Mattsson-Carlgren, Nicholas J. Ashton, Jörg Hanrieder, Henrik Zetterberg, Michael Schöll, Ross W. Paterson
Published 2020-06-01